Nantahala Capital Management, LLC 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:46 pm Sale |
2022-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Nantahala Capital Management, LLC | 29,204 1.400% |
-670,969 (-95.83%) |
Filing |
| 2022-02-14 08:05 am Purchase |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Nantahala Capital Management, LLC | 700,173 8.800% |
227,249 (+48.05%) |
Filing |
| 2021-02-12 3:18 pm Purchase |
2020-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Nantahala Capital Management, LLC | 472,924 8.400% |
201,200 (+74.05%) |
Filing |